Symptomatic Non-erosive Gastroesophageal Reflux Disease
2 clinical trials · Condition
◉ Watch Symptomatic Non-erosive Gastroesophageal Reflux Disease
| Record | Firm | Date |
|---|---|---|
| A Study to Evaluate the Efficacy and Safety of Vonoprazan 10 mg Compared to Placebo for Relief of Episodic Heartburn in Participants With Symptomatic Non-Erosive Gastroesophageal Reflux Disease Through 24 Weeks (NCT07752407) | Phathom Pharmaceuticals, Inc. | 2026-09-25 |
| A Study of the Safety of Vonoprazan Exposure in Pregnant Women and Their Offspring (NCT06660342) | Phathom Pharmaceuticals, Inc. | 2025-05-15 |
Track Symptomatic Non-erosive Gastroesophageal Reflux Disease automatically
Every clearance here is in the API, with alerts when new ones post.